LBA1 Multicenter Phase II Trial of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma after Progression on First-Line Atezolizumab Plus Bevacizumab (KCSG HB23-04)
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of Oncology(2024)